Metraipolis › archive › dc_e2045d361fc5
Implementation of guideline-recommended organ-protective therapy in people with type 2 diabetes and cardiovascular disease, heart failure, or kidney disease:… — Europe PMC PMID:41567800
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41567800
- DOI
- 10.3389/fendo.2025.1736984
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T01:14:26.261Z
- SHA-256 of the archived text
f6d29b13ef04f0a19807d6f57e6e43b57c69a4d415693e2155014249f5b2a83e- Stable URL of this page
https://metraipolis.com/documento/dc_e2045d361fc5
How to cite
Implementation of guideline-recommended organ-protective therapy in people with type 2 diabetes and cardiovascular disease, heart failure, or kidney disease:… — Europe PMC PMID:41567800 — Europe PMC (en), https://europepmc.org/article/MED/41567800 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e2045d361fc5 (Metraipolis archive dc_e2045d361fc5, sha256 f6d29b13ef04f0a19807d6f57e6e43b57c69a4d415693e2155014249f5b2a83e)
BibTeX
@misc{dce2045d361fc5,
title = {Implementation of guideline-recommended organ-protective therapy in people with type 2 diabetes and cardiovascular disease, heart failure, or kidney disease:… — Europe PMC PMID:41567800},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41567800},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e2045d361fc5; sha256 f6d29b13ef04f0a19807d6f57e6e43b57c69a4d415693e2155014249f5b2a83e},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41567800. Agents can read the archived copy with the MCP tool read_document.